M. Ciprotti - Dept Expt Med, Univ Roma La Sapienza

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Challenges and Solutions During the COVID Pandemic for Patient Retention and Physician Engagement in the Phase 3 ATLAS Study of Apalutamide Added to Androgen Deprivation Therapy (ADT) in High-Risk Localized or Locally Advanced Prostate Cancer (HRLPC)

H. M. Sandler,N. Shore,D. Dearnaley,S. J. Freedland, M. R. Smith, R. Rosales,S. D. Brookman-May,A. P. Dicker,M. R. McKenzie,A. Bossi,A. Widmark,T. Wiegel, J. Martin,B. Miladinovic,F. Lefresne,M. Ciprotti,S. A. McCarthy,S. D. Mundle,B. F. Tombal,F. Y. Feng

International journal of radiation oncology, biology, physicsno. 3 (2022): e244-e245

引用0浏览0引用

A phase III, randomized, double-blind trial of nivolumab or placebo combined with docetaxel for metastatic castration-resistant prostate cancer (mCRPC; CheckMate 7DX)

C. G. Drake,F. Saad,W. R. Clark,M. Ciprotti, B. Sharkey,S. K. Subudhi,K. Fizazi

Annals of Oncology（2020）

引用6浏览0引用

LBA52Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD

K Fizazi,P Gonzalez Mella,D Castellano,J N Minatta,A Rezazadeh Kalebasty, D Shaffer,J C Vazquez Limon,A J Armstrong, H M Sanchez Lopez, B Sharkey,A Saci, J Li,X Wang,M Ciprotti, P Sathyanarayana,F Saad,D P Petrylak, M M Retz, R K Pachynski,C Drake

ANNALS OF ONCOLOGY（2019）

引用12浏览0引用

An Open-Label, Phase 2 Study of Nivolumab in Combination with Either Rucaparib, Docetaxel, or Enzalutamide in Men with Castration-Resistant Metastatic Prostate Cancer (mcrpc; CheckMate 9KD)

C. Gruellich,K. Fizazi,C. Drake,D. Shaffer,R. Pachynski,F. Saad,M. Ciprotti,G. Kong,C. Ryan,D. Petrylak

Journal of clinical oncology（2018）

引用9浏览0引用

323 A Pilot Study of the Safety, Efficacy and Effects on Functional Imaging of the Combination of CG250 and Sunitinib in Patients (pts) with Advanced Renal Cell Carcinoma (RCC)

Marika Ciprotti,Ian D. Davis,David Pook,F.T. Lee,S.T. Lee,Graeme O’Keefe, Henri Tochon‐Danguy,Fiona E. Smyth,Wendie Hopkins,Andrew M. Scott

European Journal of Cancer (2012): 99-99

引用22浏览0引用

Octreoscan in association with 16-MDCT and neuroendocrine tumor markers in the management and therapeutical stratification of GEP tumor patients

Benedetta Criscuoli,Silvia Remediani,M Ciprotti,Enrico Cortesi,Rita Massa,Giuseppe De Vincentis

mag（2008）

引用23浏览0引用

Octreoscan In Association With Ct And Cga Serum Levels In Therapeutical Stratification Of Patients Affected By Gep Tumors

B. Criscuoli,Remediani Silvia,M. Ciprotti,Cortesi Enrico,A. Fabbri,Massa Rita,Vincentis Giuseppe De

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2007）

引用23浏览0引用

Neo-Adjuvant and Adjuvant Chemotherapy in Bladder Cancer

G. D'Auria,M. Ciprotti,D. Conte,R. Iacovelli,A. Palazzo,A. Pellegrino,E. Cortesi

Annals of oncology（2007）

引用3浏览0WOS引用

Significance of octreoscan, CT and serum chromogranin-a in the management of patients affected by gastroenteropancreatic tumors

M. Ciprotti,B. Criscuoli,M. Puglisi,A. Fabbri,L. Trani,S. Remediani,G. De Vincentis,E. Cortesi

ANNALS OF ONCOLOGY（2007）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn